FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q89875247> ?p ?o ?g. }

• Q89875247 description "2020 nî lūn-bûn" @default.
• Q89875247 description "2020年の論文" @default.
• Q89875247 description "2020年学术文章" @default.
• Q89875247 description "2020年学术文章" @default.
• Q89875247 description "2020年学术文章" @default.
• Q89875247 description "2020年学术文章" @default.
• Q89875247 description "2020年学术文章" @default.
• Q89875247 description "2020年学术文章" @default.
• Q89875247 description "2020年學術文章" @default.
• Q89875247 description "2020年學術文章" @default.
• Q89875247 description "2020年學術文章" @default.
• Q89875247 description "2020年學術文章" @default.
• Q89875247 description "2020年學術文章" @default.
• Q89875247 description "2020년 논문" @default.
• Q89875247 description "article científic" @default.
• Q89875247 description "article scientific" @default.
• Q89875247 description "article scientifique" @default.
• Q89875247 description "articol științific" @default.
• Q89875247 description "articolo scientifico" @default.
• Q89875247 description "artigo científico" @default.
• Q89875247 description "artigo científico" @default.
• Q89875247 description "artigo científico" @default.
• Q89875247 description "artikel ilmiah" @default.
• Q89875247 description "artikull shkencor" @default.
• Q89875247 description "artikulong pang-agham" @default.
• Q89875247 description "artykuł naukowy" @default.
• Q89875247 description "artículo científico publicado en 2020" @default.
• Q89875247 description "artículu científicu" @default.
• Q89875247 description "bilimsel makale" @default.
• Q89875247 description "bài báo khoa học" @default.
• Q89875247 description "naučni članak" @default.
• Q89875247 description "scienca artikolo" @default.
• Q89875247 description "scientific article published on 25 February 2020" @default.
• Q89875247 description "scientific article published on 25 February 2020" @default.
• Q89875247 description "scientific article published on 25 February 2020" @default.
• Q89875247 description "teaduslik artikkel" @default.
• Q89875247 description "tieteellinen artikkeli" @default.
• Q89875247 description "tudományos cikk" @default.
• Q89875247 description "vedecký článok" @default.
• Q89875247 description "vetenskaplig artikel" @default.
• Q89875247 description "videnskabelig artikel udgivet 25. februar 2020" @default.
• Q89875247 description "vitenskapelig artikkel" @default.
• Q89875247 description "vitskapeleg artikkel" @default.
• Q89875247 description "vědecký článek" @default.
• Q89875247 description "wetenschappelijk artikel" @default.
• Q89875247 description "wissenschaftlicher Artikel" @default.
• Q89875247 description "επιστημονικό άρθρο" @default.
• Q89875247 description "мақолаи илмӣ" @default.
• Q89875247 description "наукова стаття, опублікована в лютому 2020" @default.
• Q89875247 description "научна статия" @default.
• Q89875247 description "научная статья" @default.
• Q89875247 description "научни чланак" @default.
• Q89875247 description "научни чланак" @default.
• Q89875247 description "מאמר מדעי" @default.
• Q89875247 description "مقالة علمية نشرت في 25 فبراير 2020" @default.
• Q89875247 description "২৫ ফেব্রুয়ারি ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q89875247 description "บทความทางวิทยาศาสตร์" @default.
• Q89875247 description "სამეცნიერო სტატია" @default.
• Q89875247 name "TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)" @default.
• Q89875247 name "TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)" @default.
• Q89875247 type Item @default.
• Q89875247 label "TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)" @default.
• Q89875247 label "TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)" @default.
• Q89875247 prefLabel "TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)" @default.
• Q89875247 prefLabel "TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)" @default.
• Q89875247 P1433 Q89875247-4BF3B07E-D200-4DD4-B453-60A255088A80 @default.
• Q89875247 P1476 Q89875247-EE73F0C6-19B0-4834-B45A-ACB2DA9A4787 @default.
• Q89875247 P2093 Q89875247-07FDFE36-B128-4316-B45B-86CA152B1D42 @default.
• Q89875247 P2093 Q89875247-1857D60C-C645-4D84-A4F5-480B5763762A @default.
• Q89875247 P2093 Q89875247-1E225E0C-C1F4-4AB5-BAC8-1E9B9F6B122E @default.
• Q89875247 P2093 Q89875247-1E5BBC79-0F04-49E4-9F53-799A7F3DE5DF @default.
• Q89875247 P2093 Q89875247-3B808E1D-8832-4C04-A6E5-020DDEFC738F @default.
• Q89875247 P2093 Q89875247-5F0F69EA-A48E-4865-AFE2-86128A2F3EF8 @default.
• Q89875247 P2093 Q89875247-89B0E863-BF68-4D42-8C7C-17025613F27A @default.
• Q89875247 P2093 Q89875247-9D4BBA6C-05D5-4CC5-A23B-2CE37B74C021 @default.
• Q89875247 P2093 Q89875247-A7F7CB29-F404-4BB8-A86C-F45A4058D4DB @default.
• Q89875247 P2093 Q89875247-ACB0A7FD-32AF-44AE-92FE-64456CE42407 @default.
• Q89875247 P2093 Q89875247-BD2344C5-7F8C-42E4-AF94-11EDB1525491 @default.
• Q89875247 P2093 Q89875247-D69B74CF-50E3-44C2-B5F4-DC2D16F4481D @default.
• Q89875247 P2093 Q89875247-EE7E35F6-D78B-400B-87F6-CB0385A9CA8A @default.
• Q89875247 P2093 Q89875247-F09D79DF-777A-418C-AF12-58A6A2319057 @default.
• Q89875247 P304 Q89875247-5C59AD48-97A8-4CAE-9F56-E4D952909026 @default.
• Q89875247 P31 Q89875247-3109A038-D993-45D2-A7F4-0C4B34D34672 @default.
• Q89875247 P356 Q89875247-17F4931D-C3D6-4E93-BF7A-1F718DAE8CA8 @default.
• Q89875247 P50 Q89875247-11E8E7C8-987F-45C5-A582-3AF971135244 @default.
• Q89875247 P50 Q89875247-2A90240C-A943-461B-8B52-D37C20DD6F7F @default.
• Q89875247 P50 Q89875247-7F99C09F-73EC-46EF-B30D-9C729269D700 @default.
• Q89875247 P50 Q89875247-9D3B31E4-537C-4360-81FD-734F711C1163 @default.
• Q89875247 P50 Q89875247-DDC2167D-6065-4A48-A601-5C8C3BDE8B4A @default.
• Q89875247 P577 Q89875247-F2F8146A-636E-4A31-BCF8-98D082F47DC6 @default.
• Q89875247 P698 Q89875247-4D0236B4-A66C-442D-8EC0-1B05A13EA9B1 @default.
• Q89875247 P921 Q89875247-AA68426F-EAB8-4AF1-9291-28950AC2A53A @default.
• Q89875247 P932 Q89875247-E0806E1B-6EFF-40A3-B38C-B1EAE411FADA @default.
• Q89875247 P356 JCO.19.03292 @default.
• Q89875247 P698 32097092 @default.
• Q89875247 P1433 Q400292 @default.
• Q89875247 P1476 "TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)" @default.
• Q89875247 P2093 "Andrew J Goss" @default.
• Q89875247 P2093 "Antonio C Wolff" @default.
• Q89875247 P2093 "Banu Arun" @default.

• next